Position in PFE
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,011,360
-$168,000 QoQ
Shares Held
42,000
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#1,319
of 2,821 holders
Holding Since
Dec 2021
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HUSSMAN STRATEGIC ADVISORS, INC. holds $8,590,428 across 3 Drug Manufacturers - General names. PFE ranks #3 (11.8% of the industry book) .
All Filings in PFE
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,011,360 | 42,000 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,179,360 | 42,000 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,045,800 | 42,000 | Shares | Sole | 2026-02-02 | |
| 2025-03-31 | $1,596,420 | 63,000 | Shares | Sole | 2025-05-05 | |
| 2024-06-30 | $1,175,160 | 42,000 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $2,913,750 | 105,000 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $3,627,540 | 126,000 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $3,449,680 | 104,000 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $3,814,720 | 104,000 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $5,059,200 | 124,000 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $6,353,760 | 124,000 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $5,426,240 | 124,000 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $4,875,990 | 93,000 | Shares | Sole | 2022-09-12 | |
| 2022-03-31 | $3,499,652 | 67,600 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $3,377,660 | 57,200 | Shares | Sole | 2022-01-31 | |
| No filing history on record for this holder in this stock. | ||||||